CFH (rs1061170, rs1410996), KDR (rs2071559, rs1870377) and KDR and CFH Serum Levels in AMD Development and Treatment Efficacy.
Dzastina CebatorieneAlvita VilkeviciuteGreta GedvilaiteAkvile BruzaiteLoresa KriauciunieneDalia ZaliunieneRasa LiutkevicienePublished in: Biomedicines (2024)
polymorphisms influence susceptibility to AMD but do not correlate with a response to anti-VEGF therapy. Further research is imperative to fully evaluate the developmental significance, treatment efficacy, and predictive role in influencing susceptibility to anti-VEGF therapy for KDR and CFH.